Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Jul 5:13:37.
doi: 10.1186/s13020-018-0193-x. eCollection 2018.

Siegesbeckia pubescens Makino inhibits Pam3CSK4-induced inflammation in RAW 264.7 macrophages through suppressing TLR1/TLR2-mediated NF-κB activation

Affiliations

Siegesbeckia pubescens Makino inhibits Pam3CSK4-induced inflammation in RAW 264.7 macrophages through suppressing TLR1/TLR2-mediated NF-κB activation

Wei Sang et al. Chin Med. .

Abstract

Background: Siegesbeckia pubescens Makino (SP) is one of the important plant origins for the anti-inflammatory Chinese herbal medicine of Siegesbeckiae Herba. The current investigations indicated that the anti-inflammatory effects of SP were associated with the toll-like receptors (TLRs)-mediated nuclear factor-κB (NF-κB) and the mitogen-activated protein kinase (MAPK) signaling pathways.

Methods: Raw 264.7 macrophages were pretreated with the 50% ethanol extract of SP (SPE, 50-200 µg/mL) and then co-treated with Pam3CSK4 (200 ng/mL) for another 12 h. The inhibitory effect of SPE on Pam3CSK4-stimulated NO release and post-inflammatory cytokines secretions were determined using Griess reagent and Elisa kits, respectively. The influence of SPE on NF-κB and MAPKs signaling relevant proteins was measured by Western blotting analysis, while the intracellular nitric oxide (NO) generation and NF-κB/p65 nuclear translocation were determined using Leica TCS SP8 laser scanning confocal microscope. Moreover, the effect of SPE on luciferase reporter gene in NF-κB-luc DNA transfected raw 264.7 cells was determined using the Dual-Glo luciferase assay system kit.

Results: SPE dose-dependently (50-200 µg/mL) attenuated Pam3CSK4-induced NO release, post-inflammatory cytokines (IL-6, TNF-α and MCP-1) secretions and intracellular NO generation in raw 264.7 cells. Biologically, SPE suppressed Pam3CSK4-induced expressions of cyclooxygenase-2 (COX-2), inducible nitric oxide synthase (iNOS), phosphorylation of NF-κB/p65 and IκBα, but did not significantly show effect on the proteins involved in MAPKs signaling (p38, ERK and JNK). The results were further confirmed by NF-κB-luc reporter gene assay and p65 nuclear translocation assay.

Conclusions: In conclusion, SPE ameliorated Pam3CSK4-induced inflammation in raw 264.7 cells through suppressing TLR 1/2-mediated NF-κB activation.

Keywords: Inflammation; NF-κB; Pam3CSK4; Siegesbeckia pubescens Makino; Toll-like receptor 1/2.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
HPLC chromatograms of (a) mixed standards (7.5 μg/mL of rutin, kirenol and darutoside) and (b) SPE (1 mg/mL). 1: rutin; 2: kirenol; 3: darutoside. The contents of rutin, kirenol and darutoside were determined to be 0.27 ± 0.01, 1.81 ± 0.02 and 0.28 ± 0.03%, respectively (n = 3)
Fig. 2
Fig. 2
Siegesbeckia pubescens Makino (SP) or SP with Pam3CSK4-stimulated did not significantly affect the cell viability and cytotoxicity (n = 3). RAW 264.7 cells were treated with SP with different concentrations for 24 h. a The cell viability was measured by MTT assay and c cell cytotoxicity was measured by LDH assay. RAW 264.7 cells were pretreated with SP for 4 h before Pam3CSK4 (200 ng/mL) stimulation for another 12 h. b The cell viability was measured by MTT assay and d cell cytotoxicity was measured by LDH assay
Fig. 3
Fig. 3
Siegesbeckia pubescens Makino (SP) exhibited anti-inflammatory effects in Pam3CSK4-stimulated RAW 264.7 cells (n = 3). RAW 264.7 cells were pretreated with SP with different concentrations for 4 h before Pam3CSK4 (200 ng/mL) stimulation for another 12 h. a Nitric oxide (NO) was determined by Griess assay. TLR1/TLR2 antagonist: CU-CPT22 (CU) was selected as the positive control. We measured the levels of b IL-6, c TNF-α, and d MCP-1 by ELISA assay. *P < 0.05 vs. Pam3CSK4-induced, **P < 0.01 vs. Pam3CSK4-induced, ***P < 0.001 vs. Pam3CSK4-induced
Fig. 4
Fig. 4
RAW 264.7 cells were pretreated with Siegesbeckia pubescens Makino (SP) (n = 3) for 4 h before Pam3CSK4 (200 ng/mL) stimulation for another 12 h. NO was captured by Leica TCS SP8 laser scanning confocal microscope with 5 μM DAF-FM diacetate (4-amino-5-methylamino-2′,7′-difluorofluorescein diacetate). CU-CPT22 (CU) is selected as the positive control
Fig. 5
Fig. 5
Effects of Siegesbeckia pubescens Makino (SP) on relevant pathways. RAW 264.7 cells were pretreated with SP (0, 50, 100 and 200 μg/mL) for 4 h and followed with Pam3CSK4 (200 ng/mL) addition for 12 h. CU-CPT22 (CU) is selected as the positive control. a Proteins was evaluated by Western blotting assay. b, c Quantification of iNOS and COX-2 protein was detected by densitometric analysis (n = 3). **P < 0.01 vs. Pam3CSK4-induced
Fig. 6
Fig. 6
Effects of Siegesbeckia pubescens Makino (SP) on NF-κB pathways (n = 3). RAW 264.7 cells were pretreated with SP (0, 50, 100 and 200 μg/mL) for 2 h and followed with Pam3CSK4 (200 ng/mL) addition for 4 h. CU-CPT22 (CU) is selected as the positive control. a Proteins was evaluated by Western blotting assay. b, c Quantification was detected by densitometric analysis. d RAW 264.7 cells were transfected with NFκB-luc for 48 h. Cells were pretreated with SP 2 h before Pam3CSK4 (200 ng/mL) stimulation for another 4 h. Luciferase activity was determined by Dual-Glo Luciferase Assay. *P < 0.05 vs. Pam3CSK4-induced and **P < 0.01 vs. Pam3CSK4-induced
Fig. 7
Fig. 7
RAW 264.7 cells were pretreated with 200 μg/mL of Siegesbeckia pubescens Makino (SP) (n = 3) for 2 h before Pam3CSK4 stimulation for another 4 h. NF-κB/p65 nuclear translocation was determined by immunofluorescence assay

References

    1. Hawiger J. Innate immunity and inflammation: a transcriptional paradigm. Immunol Res. 2001;23(2–3):99–109. doi: 10.1385/IR:23:2-3:099. - DOI - PubMed
    1. Sauaia A, Moore FA, Moore EE. Postinjury inflammation and organ dysfunction. Crit Care Clin. 2017;33(1):167–191. doi: 10.1016/j.ccc.2016.08.006. - DOI - PMC - PubMed
    1. Kunnumakkara AB, Sailo BL, Banik K, Harsha C, Prasad S, Gupta SC, Bharti AC, Aggarwal BB. Chronic diseases, inflammation, and spices: how are they linked? J Transl Med. 2018;16(1):14. doi: 10.1186/s12967-018-1381-2. - DOI - PMC - PubMed
    1. Tak PP, Firestein GS. NF-kappaB: a key role in inflammatory diseases. J Clin Invest. 2001;107(1):7–11. doi: 10.1172/JCI11830. - DOI - PMC - PubMed
    1. Lawrence T. The nuclear factor NF-kappaB pathway in inflammation. Cold Spring Harb Perspect Biol. 2009;1(6):a001651. doi: 10.1101/cshperspect.a001651. - DOI - PMC - PubMed